...designed to evaluate low-voltage biventricular stimulation versus no stimulation therapy in the treatment of heart failure (HF) patients. St. Jude Medical's Genesis(TM) system consists of the Frontier(TM) 3x2 stimulation device, the Aescula(TM) LV left...

...findings: * The median length of stay was 17 days for HF patients and 14 days for cancer patients. Hospice stays exceeding...likely to receive care in their own homes. * Fully 20% of HF patients were discharged from hospice alive, compared with 11...

ORLANDO -- A standard 7-week course of enhanced external counterpulsation therapy in patients with heart failure who are on optimal pharmacotherapy improves their exercise duration, quality of life, and New York Heart Association class for at least 6 months afterward, according to the results of a

Business Editors/Health/Medical Writers STRASBOURG, FranceBUSINESS WIREJune 23, 2003 Fifty percent of patients in Europe suffering from heart failure, a life-threatening and debilitating condition, do not receive optimal treatment. This is one of the results of a new European survey presented today

BOCA RATON, FLA. -- The brain natriuretic peptide, nesiritide, which is used to treat acute heart failure symptoms, did not facilitate diuresis or protect renal function in a small study of stable hospitalized patients. Many clinicians believe that nesiritide (Natrecor, Scios Inc.) facilitates

BOCA RATON, FLA. -- Heart failure patients with atrial fibrillation who receive cardiac resynchronization devices experience benefits similar to those in patients without the condition, according to data presented at the annual meeting of the Heart Failure Society of America. Major cardiac

BOCA RATON, FLA. -- Heart failure patients with atrial fibrillation who receive cardiac resynchronization devices experience benefits similar to those in patients without the condition, according to data presented at the annual meeting of the Heart Failure Society of America. Major cardiac

SAN FRANCISCO -- Giving high-dose nitroglycerin to patients with heart failure who come to the emergency department between midnight and 8 a.m. may shorten their length of stay by nearly a day. John R. Allegra, M.D., said in a poster at the annual meeting of the American College of Emergency

SEATTLE -- A 12-week study of sildenafil therapy in patients with heart failure due to left ventricular dysfunction and secondary pulmonary hypertension is continuing after an interim analysis found neither therapeutic futility nor overwhelming improvements in exercise capacity, Dr. Gregory Lewis

...defibrillators (AICDs) in heart failure (HF) patients. Data Sources Selected scientific...developments in device therapy for HF patients are helping to decrease morbidity...morbidity and improved survival in HF patients, many patients have refractory...